People | June 11, 2022
AIkido Pharma appoints Soo Yu as Director
New Director supports NASDAQ rule on diversity
New Director supports NASDAQ rule on diversity
The company also reported the issuance of an additional U.S. patent covering the drug, and the filing of a continuation patent application intended to expand patent coverage to other facets of the drug
Cedars-Sinai Technology Ventures has had 114 patents issued for the fiscal year 2021 and has 511 active technologies under development, as of July 2021
The goal for the project is the identification and optimization of anti-viral compounds.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)